Our Recommendations
- Antimicrobial Resistance National Strategy Framework 2014 –2024 (South Africa) (2015)
- Standards for the Establishment and Operations of Model Pharmacies and Model Medicine Shops (2016)
- Malawi Standard Treatment Guidelines (MSTG) 5th Edition (2015)
- National Medicines Policy 2015 (2015)
- Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia) (2011)
New Publications
- The increasing threat of vaccine-preventable diseases in Lebanon (2024)
- Liste nationale des médicaments essentiels et autres produits de santé (2023) (2023)
- The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study (2019)
- The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review (2022)
- Ready to Use Therapeutic Food (RUFT) and the WHO Essential Medicines List (2018)
Filter
426
Featured
Recommendations
27
New Publications
133
Language
Document type
No document type
254
Guidelines
71
Studies & Reports
51
Fact sheets
13
Strategic & Response Plan
11
Manuals
8
Resource Platforms
7
Infographics
5
Videos
3
Training Material
2
Brochures
1
Countries / Regions
Ethiopia
32
Kenya
24
Uganda
23
South Africa
22
Rwanda
20
India
20
Nepal
17
Nigeria
17
Indonesia
15
Burkina Faso
13
Malawi
13
Zimbabwe
13
Bangladesh
13
Ghana
12
Chile
12
Tanzania
12
Zambia
12
Haiti
11
Ukraine
9
Benin
9
Botswana
9
Sierra Leone
8
Namibia
7
Lesotho
6
Bolivia
6
Myanmar / Burma
6
Senegal
5
Congo, Democratic Republic of
5
Paraguay
5
Liberia
5
Eswatini/ Swaziland
5
Philippines
4
Eastern Europe and Central Asia
4
Argentina
4
Central African Republic
4
Colombia
3
Latin America and the Carribbean
3
West and Central Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Madagascar
3
Mozambique
2
Global
2
Cambodia
2
Germany
2
United Kingdom
2
East and Southern Africa
2
North Macedonia
1
Tajikistan
1
Thailand
1
Serbia
1
Australia
1
China
1
Kazakhstan
1
Syria
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Armenia
1
Africa
1
Guinea-Bissau
1
Venezuela
1
South–East Asia Region
1
Lebanon
1
Brazil
1
Russia
1
Sudan
1
Georgia
1
Angola
1
Chad
1
Libya
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Toolboxes
Pharmacy
67
AMR
21
COVID-19
13
Conflict
4
TB
3
NCDs
3
Refugee
1
Planetary Health
1
Accessed on 10.09.2022
Para evaluar la situación basal de los PROA en Chile, el grupo iniciativa del Milenio para la Investigación Colaborativa en Resistencia Bacteriana (MICROB-R), realizó una encuesta que en colaboración con el Ministerio de Salud debía ser respondida por los hospitales p...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
Rational of the Standard Treatment Protocol (STP)
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Background: Asthma and chronic obstructive pulmonary disease (COPD) cause a considerable burden of morbidity
and mortality in low-income and middle-income countries (LMICs). Access to safe, effective, quality-assured, and
affordable essential medicines is variable. We aimed to review the existing ...
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
Die Liste wird kontinuierlich aktualisiert und beinhaltet die entsprechenden Tests zur professionellen Anwendung, die sich nach aktueller Kenntnis des BfArM in Deutschland in Verkehr befinden und laut den Herstellerangaben die jeweils aktuellen durch das Paul-Ehrlich-Institut (PEI) in Abstimmung mit...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Antimicrobial Resistance or AMR continues to pose a major threat to human development and to the fight against infectious diseases. It also endangers animal health and welfare, and food production, and severely impacts our economies and societies. An holistic approach must be used to mitigate AMR ri...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
